Phase I Study of Gemcitabine or S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer

NCT01291615 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

NETWORK

Sponsor class

Conditions

Biliary Tract Cancer

Interventions

DRUG: Gemcitabine
DRUG: S-1

Sponsor

Kansai Hepatobiliary Oncology Group